Relating to Medicaid reimbursement for certain medication-assisted treatments for opioid or substance use disorder.
Relating to health benefit plan coverage of prescription drugs for serious mental illnesses and opioid and substance use disorders.
Relating to Medicaid coverage and reimbursement for non-opioid treatments.
Relating to Medicaid coverage and reimbursement for certain cancer-related treatments or items.
Relating to health benefit plan coverage for treatment of autism spectrum disorders.
Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.
Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.
Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.
Relating to Medicaid coverage and reimbursement for the provision of rapid whole genome sequencing to certain infants with acute or complex illnesses.
Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.